Skip to main content

Table 2 Mild or moderate adverse events

From: Randomized double-blind placebo-controlled multicenter trial for the effects of a polyherbal remedy, Yokukansan (YiganSan), in smokers with depressive tendencies

 

Placebo (n = 97)

Yokukansan (n = 94)

P-value

Gastrointestinal symptoms

n = 11

11%

n = 11

12%

 > .999

Infection

n = 1

1%

n = 3

3%

.363

Neurotic symptoms

n = 3

3%

n = 2

2%

 > .999

Respiratory symptoms

n = 1

1%

n = 1

1%

 > .999

Unidentified complaints

n = 1

1%

n = 2

2%

.617

Hypokalemia

n = 3

3%

n = 0

0%

.246

Liver damage

n = 1

1%

n = 0

0%

 > .999

  1. Gastrointestinal symptoms: nausea, vomiting, epigastralgia, constipation, diarrhea, abdominal fullness
  2. Infection: common cold, bacterial pneumonia, otitis media, influenza
  3. Neurotic symptoms: nightmares, headache, sleepiness
  4. Respiratory symptoms: dyspnea, worsening of COPD
  5. Unidentified symptoms: general malaise, palpitation, stiff shoulder
  6. p-value: Fisher’s exact test
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us